# ADMA Biologics, Inc. (ADMA) stock: price and valuation

URL: https://funkfolio.com/stock/ADMA

> ADMA Biologics, Inc. (ADMA) trades at $13.51, is worth $3B, is priced at 17.5× earnings and scores 71/100. Valuation, financials and signals.

---

## ADMA Biologics, Inc. (ADMA)

ADMA Biologics, Inc. (ADMA) is a healthcare company (biotechnology) based in the United States. The share price is $13.51, up 0.30% on the day, which values the company at $3B. Price as of 17 Nov 2026, 18:22 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $13.51 +0.30% today
- **Market value:** $3B
- **P/E ratio:** 17.5× last 12 months
- **Forward P/E:** 14.4×
- **Funk Score:** 71/100
- **Against its own history:** Above its usual price usual price $12.22
- **200-week average:** $11.40 18% above
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 18:22 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### ADMA Biologics, Inc. in more detail

ADMA trades at 17.5× its last twelve months' earnings, 14.4× next year's expected earnings, 5.8× sales. Measured against its own history, the price is 11% above what its usual multiples would imply ($12.22) — above its usual price. It sits 18% above its 200-week average of $11.40.

Over the last five fiscal years ADMA Biologics, Inc. has compounded revenue 64.6% a year. Its Funk Score is 71 out of 100 (financial strength 8.9, profitability 6.9, growth 10.0, value 2.8, each out of 10).

In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Beneish M-score flags the accounts; Share count keeps rising.

2 of the superinvestors tracked here hold ADMA, including Stanley Druckenmiller (0.5% of the portfolio), Terry Smith (0.1% of the portfolio).

### Superinvestors holding ADMA

2 of the investors tracked here report a position in their latest 13F filing.

- [Stanley Druckenmiller Duquesne Family Office](https://funkfolio.com/gurus/stanley-druckenmiller) 0.54% of portfolio · $23.3M · added · Q2 2026
- [Terry Smith Fundsmith](https://funkfolio.com/gurus/terry-smith) 0.13% of portfolio · $16.5M · Q3 2026

### ADMA Biologics, Inc. (ADMA): questions and answers

**What is ADMA's P/E ratio?**

ADMA Biologics, Inc. trades at 17.5× its last twelve months' earnings and 14.4× next year's expected earnings.

**What is ADMA Biologics, Inc.'s market cap?**

ADMA Biologics, Inc. is valued at $3B at a share price of $13.51.

**Is ADMA overvalued or undervalued?**

Against its own history, ADMA is above its usual price: the price is 11% above the $12.22 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is ADMA above its 200-week moving average?**

Yes. ADMA is 18.5% above its 200-week average of $11.40. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is ADMA Biologics, Inc. growing?**

Over the last five fiscal years ADMA Biologics, Inc.'s revenue grew 64.6% a year; over ten years revenue grew 53.2% a year.

**Does ADMA pay a dividend?**

ADMA Biologics, Inc. does not currently pay a regular dividend.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “ADMA Biologics, Inc. (ADMA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ADMA

Underlying data: Yahoo Finance; company filings with the SEC.
